## Antibiotic Management of Postpartum Mastitis **Key Point:** Beta-lactam antibiotics (flucloxacillin or cephalexin) are the first-line agents for lactation-preserving mastitis treatment because they are effective against *Staphylococcus aureus*, safe in breast milk, and allow continued breastfeeding. ### Pathophysiology of Mastitis Mastitis typically results from milk stasis and bacterial colonization (most commonly *Staphylococcus aureus*, including MRSA in some settings). Continued milk removal (breastfeeding or expression) is essential to prevent abscess formation and is compatible with appropriate antibiotic therapy. ### First-Line Antibiotic Regimens | Agent | Spectrum | Breast Milk Safety | Dosing | Notes | |-------|----------|-------------------|--------|-------| | **Flucloxacillin** | *S. aureus* (including MSSA) | Safe | 500 mg QID × 10–14 days | Preferred in UK/Commonwealth | | **Cephalexin** | *S. aureus*, Gram-positive | Safe | 500 mg QID × 10–14 days | First-generation cephalosporin; preferred in US | | **Amoxicillin-clavulanate** | Broader spectrum | Safe | 875/125 mg BD × 10–14 days | Alternative if MRSA coverage needed | | **Tetracycline** | Broad | **NOT safe** | — | Deposits in bone/teeth; contraindicated | | **Metronidazole** | Anaerobes | Minimal evidence | — | No role in mastitis (not anaerobic) | **High-Yield:** The combination of **beta-lactam antibiotic + continued breastfeeding + supportive care (analgesia, heat, milk removal)** is the gold standard and prevents 90% of abscess formation. ### Adjunctive Management 1. **Milk removal:** Continue breastfeeding or express milk regularly 2. **Analgesia:** Paracetamol or ibuprofen (safe in lactation) 3. **Local measures:** Warm compresses, breast support 4. **Duration:** Antibiotics for 10–14 days; clinical improvement expected by 48–72 hours **Clinical Pearl:** If mastitis does not resolve within 48–72 hours of appropriate antibiotics, suspect **breast abscess** and obtain ultrasound for drainage consideration. ### MRSA Considerations If MRSA is suspected or confirmed (e.g., healthcare-associated infection): - **First-line:** Trimethoprim-sulfamethoxazole (TMP-SMX) or clindamycin - **Avoid:** Fluoroquinolones (limited data in lactation) **Warning:** Do NOT use tetracyclines, fluoroquinolones, or metronidazole as first-line agents in lactating women; they either concentrate in breast milk or lack evidence of safety. [cite:RCOG Green-top Guideline 64; Williams Obstetrics 26e Ch 37]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.